Raleigh Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Buy
442
+2
+0.5% +$874 0.06% 210
2026
Q1
$203K Buy
440
+70
+19% +$35.4K 0.07% 199
2025
Q4
$210K Buy
370
+28
+8% +$14.9K 0.08% 193
2025
Q3
$153K Buy
342
+35
+11% +$16.8K 0.06% 205
2025
Q2
$167K Buy
307
+59
+24% +$30.9K 0.07% 213
2025
Q1
$123K Sell
248
-70
-22% -$38.7K 0.06% 224
2024
Q4
$166K Buy
318
+24
+8% +$12.5K 0.06% 212
2024
Q3
$144K Buy
294
+10
+4% +$4.66K 0.06% 227
2024
Q2
$126K Buy
284
+68
+31% +$27.1K 0.05% 229
2024
Q1
$86.2K Buy
216
+175
+427% +$66.1K 0.04% 250
2023
Q4
$13.8K Buy
+41
New +$12.2K 0.01% 510
2022
Q1
Sell
-15
Closed -$5K 641
2021
Q4
$5K Buy
+15
New +$5.16K 0.01% 235

Other funds holding ISRG

Raleigh Capital Management's ISRG Position: Q2 2026 in Review

Raleigh Capital Management increased its Intuitive Surgical (ISRG) stake by 0.45% in Q2 2026, buying an estimated $874 and bringing the position to 442 shares worth $176K. The position accounts for 0.06% of the portfolio, ranked #210.

Raleigh Capital Management first reported a position in ISRG in Q4 2021 and has held it in 12 quarters since. The position peaked at $210K in Q4 2025. 716 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Raleigh Capital Management held 442 shares of Intuitive Surgical worth $176K as of Q2 2026.
  • Raleigh Capital Management bought 2 Intuitive Surgical shares in Q2 2026, an estimated $874.
  • Intuitive Surgical made up 0.06% of Raleigh Capital Management's portfolio in Q2 2026, its #210 holding.
  • Raleigh Capital Management first reported a position in Intuitive Surgical in Q4 2021 and has held it in 12 quarters since.
  • Raleigh Capital Management's Intuitive Surgical position peaked at $210K in Q4 2025.
  • 716 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.